Nestlé has agreed to acquire core vitamin and supplement brands of The Bountiful Company from investment firm KKR for $5.75 billion, as it looks to expand its health and nutrition portfolio.
The Bountiful Company is a US manufacturer and seller of vitamins, minerals, herbal and other speciality supplements and active nutrition products.
The deal includes brands such as Nature’s Bounty, Solgar, Osteo Bi-Flex and Puritan’s Pride, as well as the company’s US private label business. In the last 12 months, these brands recorded net sales of $1.87 billion.
Upon completion, the brands will be integrated into Nestlé Health Science – joining its existing brands including Garden of Life, Vital Proteins, Persona Nutrition, Pure Encapsulations and Genestra.
Meanwhile, The Bountiful Company’s sports and active nutrition brands – Pure Protein, Body Fortress and Met-Rx – as well as its personal care brand Dr.Organic and Canadian over-the-counter (OTC) business are not included in the sale.
The acquisition marks another move by Nestlé to grow its health portfolio – which helped the company beat its full-year expectations – and become a leader in vitamins, minerals and nutritional supplements. Unilever is also building its consumer health portfolio and recently agreed to acquire US supplements brand Onnit.
“Vitamins and supplements are a key part of our business and have contributed to strong growth acceleration,” said Nestlé Health Science CEO, Greg Behar.
“This acquisition complements our existing health and nutrition portfolio in terms of brands and channels. It will establish Nestlé Health Science as the industry leader in mass retail, specialty retail, ecommerce and direct-to-consumer in the US, while offering significant opportunities for geographic growth.”
KKR acquired a majority interest in The Bountiful Company from The Carlyle Group back in 2017, with the latter retaining a minority stake in the company and therefore also involved in this agreement.
“Since KKR’s investment, The Bountiful Company has transformed into a leading, fast growth, pure-play nutrition platform through significant investments in talent, brand building, R&D, ecommerce, and manufacturing capabilities,” said Felix Gernburd, managing director at KKR.
Paul Sturman, president and CEO of The Bountiful Company, said: “Today’s announcement from Nestlé Health Science recognises the transformation of The Bountiful Company over the past three+ years, as well as the collective value and capability of the organisation.
“As a leader in global nutrition, we take seriously our responsibility and role in consumers’ health and wellness. We’re incredibly proud of the trusted brands we’ve built and are confident that they will be strong assets for Nestlé.”
The transaction is expected to close in the second half of 2021, subject to regulatory approvals and customary closing conditions.
By Emma Upshall
Source: foodbev.com
Danone has appointed Carla Hilhorst to the newly created position of senior vice president of research and innovation categories and zones, as the company looks to make science the heart of its business. Hilhorst, who brings over 30 years of experience in research and innovation, will report directly to Isabelle Esser, Danone’s chief research, innovation, quality and food safety officer.
The move, part of Pernod Ricard’s strategy to enhance its premiumisation efforts, will allow the company to focus more resources on its portfolio of premium international spirits and champagne brands that drive the growth of its business. This decision aligns with the company’s commitment to delivering sustainable value for shareholders, employees, clients and partners.
Schai – who is the current CEO of Swiss chocolate company Lindt & Sprüngli’s Australian operation – has previously worked with Aryzta from 2015-2018, where he served in roles including managing director for Asia Pacific and global strategic business lead (McDonald’s). The fast-food giant McDonald’s is one of Aryzta’s significant clients.
